Literature DB >> 25078695

Human herpesvirus 8 viral interleukin-6 signaling through gp130 promotes virus replication in primary effusion lymphoma and endothelial cells.

Emily Cousins1, Yang Gao1, Gordon Sandford1, John Nicholas2.   

Abstract

The contributions of human herpesvirus 8 (HHV-8) viral interleukin-6 (vIL-6) to virus biology remain unclear. Here we examined the role of vIL-6/gp130 signaling in HHV-8 productive replication in primary effusion lymphoma and endothelial cells. Depletion and depletion-complementation experiments revealed that endoplasmic reticulum-localized vIL-6 activity via gp130 and gp130-activated signal transducer and activator of transcription (STAT) signaling, but not extracellular signal-regulated kinase (ERK) activation, was critical for vIL-6 proreplication activity. Our data significantly extend current understanding of vIL-6 function and associated mechanisms in HHV-8 biology.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078695      PMCID: PMC4178734          DOI: 10.1128/JVI.01751-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.

Authors:  Y Aoki; E S Jaffe; Y Chang; K Jones; J Teruya-Feldstein; P S Moore; G Tosato
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

2.  A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant.

Authors:  J S Cannon; D Ciufo; A L Hawkins; C A Griffin; M J Borowitz; G S Hayward; R F Ambinder
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit.

Authors:  J Molden; Y Chang; Y You; P S Moore; M A Goldsmith
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

4.  Structure of an extracellular gp130 cytokine receptor signaling complex.

Authors:  D Chow ; X He ; A L Snow; S Rose-John; K C Garcia
Journal:  Science       Date:  2001-03-16       Impact factor: 47.728

5.  Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6.

Authors:  X Wan; H Wang; J Nicholas
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells.

Authors:  K D Jones; Y Aoki; Y Chang; P S Moore; R Yarchoan; G Tosato
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

Review 7.  Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents.

Authors:  B Ensoli; M Stürzl
Journal:  Cytokine Growth Factor Rev       Date:  1998-03       Impact factor: 7.638

8.  Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.

Authors:  F Schaper; C Gendo; M Eck; J Schmitz; C Grimm; D Anhuf; I M Kerr; P C Heinrich
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

9.  Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus.

Authors:  Erin M McCartney; Karla J Helbig; Sumudu K Narayana; Nicholas S Eyre; Amanda L Aloia; Michael R Beard
Journal:  Hepatology       Date:  2013-10-01       Impact factor: 17.425

10.  Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.

Authors:  Yoshiyasu Aoki; Gerald M Feldman; Giovanna Tosato
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

View more
  9 in total

1.  Genetic Analyses of Contributions of Viral Interleukin-6 Interactions and Signaling to Human Herpesvirus 8 Productive Replication.

Authors:  Qian Li; Qiwang Xiang; Daming Chen; John Nicholas
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

2.  Human Herpesvirus 8 Interleukin-6 Interacts with Calnexin Cycle Components and Promotes Protein Folding.

Authors:  Daming Chen; Qiwang Xiang; John Nicholas
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

3.  Insulin-Like Growth Factor 2 Receptor Expression Is Promoted by Human Herpesvirus 8-Encoded Interleukin-6 and Contributes to Viral Latency and Productive Replication.

Authors:  Qian Li; Daming Chen; Qiwang Xiang; John Nicholas
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

4.  Promotion of Endoplasmic Reticulum-Associated Degradation of Procathepsin D by Human Herpesvirus 8-Encoded Viral Interleukin-6.

Authors:  Daming Chen; John Nicholas
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

5.  Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway.

Authors:  Laura Pasqualucci; Raul Rabadan; Pascale Willem; Zhaoqi Liu; Ioan Filip; Karen Gomez; Dewaldt Engelbrecht; Shabnum Meer; Pooja N Lalloo; Pareen Patel; Yvonne Perner; Junfei Zhao; Jiguang Wang
Journal:  Blood Cancer Discov       Date:  2020-07

6.  Role of JAK-STAT Pathway in Broiler Chicks Fed with Chestnut Tannins.

Authors:  Annah Lee; Gabriela Cardoso Dal Pont; Michele Battaglia; Ryan J Arsenault; Michael H Kogut
Journal:  Animals (Basel)       Date:  2021-01-29       Impact factor: 2.752

Review 7.  KSHV-Mediated Angiogenesis in Tumor Progression.

Authors:  Pravinkumar Purushothaman; Timsy Uppal; Roni Sarkar; Subhash C Verma
Journal:  Viruses       Date:  2016-07-20       Impact factor: 5.048

Review 8.  Kaposi sarcoma herpesvirus pathogenesis.

Authors:  Giuseppe Mariggiò; Sandra Koch; Thomas F Schulz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

Review 9.  KSHV: Immune Modulation and Immunotherapy.

Authors:  Grant Broussard; Blossom Damania
Journal:  Front Immunol       Date:  2020-02-07       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.